| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8dbd7182ea460f32395c4e0f781ac3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0a45da65b1059987d1e80879029f45c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aae6871e1030aa3af83343b40a3735e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee9c07ccde156972da81635611afe48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439aa34999e85b85da01c139e4b47cad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b80d63d3be4bc0a455287fe341c4dd6 |
| publicationDate |
2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2010007101-A |
| titleOfInvention |
METHODS AND AGENTS TO IMPROVE THE RECOGNITION OF TUMOR CELLS THAT EXPRESS CD138. |
| abstract |
Immunoconjugates having specificity for CD138 that reduce the adhesion of tumor cells expressing CD138 to stromal cells and methods for using them are described. This reduced adhesion makes tumor cells not only susceptible to immunoconjugates, but also to other agents in particular to cytotoxic agents. |
| priorityDate |
2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |